GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Captor Therapeutics SA (WAR:CTX) » Definitions » Market Cap

Captor Therapeutics (WAR:CTX) Market Cap : zł353.07 Mil (As of May. 24, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Captor Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Captor Therapeutics's share price for the quarter that ended in Dec. 2023 was zł99. Captor Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 4.65 Mil. Therefore, Captor Therapeutics's market cap for the quarter that ended in Dec. 2023 was zł459.93 Mil.

Captor Therapeutics's quarterly market cap declined from Jun. 2023 (zł639.79 Mil) to Sep. 2023 (zł467.03 Mil) and declined from Sep. 2023 (zł467.03 Mil) to Dec. 2023 (zł459.93 Mil).

Captor Therapeutics's annual market cap declined from Dec. 2021 (zł742.21 Mil) to Dec. 2022 (zł666.90 Mil) and declined from Dec. 2022 (zł666.90 Mil) to Dec. 2023 (zł459.93 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Captor Therapeutics's Enterprise Value for Today is zł281.15 Mil.


Captor Therapeutics Market Cap Historical Data

The historical data trend for Captor Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Captor Therapeutics Market Cap Chart

Captor Therapeutics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - - 742.21 666.90 459.93

Captor Therapeutics Quarterly Data
Dec17 Dec18 Jun19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 666.90 654.52 639.79 467.03 459.93

Competitive Comparison of Captor Therapeutics's Market Cap

For the Biotechnology subindustry, Captor Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Captor Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Captor Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where Captor Therapeutics's Market Cap falls into.



Captor Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Captor Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=zł99*4.64571
=zł459.93

Captor Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=zł99*4.64571
=zł459.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Captor Therapeutics  (WAR:CTX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Captor Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of Captor Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Captor Therapeutics (WAR:CTX) Business Description

Traded in Other Exchanges
Address
ul. Dunska 11, Wroclaw, POL, 54-427
Captor Therapeutics SA is a biopharmaceutical company. It is focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options.

Captor Therapeutics (WAR:CTX) Headlines

No Headlines